The Role of Multidimensional Prognostic Index to Identify Hospitalized Older Adults with COVID-19 Who Can Benefit from Remdesivir Treatment: An Observational, Prospective, Multicenter Study
Authors (first, second and last of 18)
Collection
COVID-19
All articles published in Drugs & Aging on the SARS-Cov-2 virus and coronavirus disease (COVID-19) since the pandemic started in 2020.
Articles (8 in this collection)
-
-
Safety, Effectiveness, and Immunogenicity 6 Months After BNT162B2 mRNA Vaccine in Frail Nursing Home Residents
Authors (first, second and last of 11)
-
Psychotropic Drug Prescription in Nursing Homes During the COVID-19 Pandemic
Authors (first, second and last of 8)
-
Safety of Remdesivir for Patients 80 Years of Age or Older with Coronavirus Disease 2019 (COVID-19)
Authors (first, second and last of 9)
-
Sex Differences in Association Between Anti-Hypertensive Medications and Risk of COVID-19 in Middle-Aged and Older Adults
Authors (first, second and last of 9)
-
Drug–Drug Interactions and Prescription Appropriateness at Hospital Discharge: Experience with COVID-19 Patients
Authors (first, second and last of 12)
-
Drug–Drug Interactions and Prescription Appropriateness in Patients with COVID-19: A Retrospective Analysis from a Reference Hospital in Northern Italy
Authors (first, second and last of 11)
-
The Cross-Talk between Age, Hypertension and Inflammation in COVID-19 Patients: Therapeutic Targets
Authors
